DBD logo

Diebold Nixdorf, Incorporated (DBD)

Profile

Full Name

Diebold Nixdorf, Incorporated

Ticker

NYSE: DBD

Exchange

NYSE

Sector

Technology

Industry

Software Development

Country

United States

IPO

August 14, 2023

Indexes

Not included

Website

https://www.dieboldnixdorf.com

Employees

21000

Key Details

Price

$65.60(0.34%)

Market Cap

$2.35B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$3.75B(-0.25% YoY)

Annual EPS

-$0.44(-101.20% YoY)

PE Ratio

48.08

Next earnings date

Feb 11, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $65.60
    DBD price is $65.60

    30-Day Relative Volume

    2.27
    DBD 30-day relative volume is 2.27

    Price Performance

    Price Most Recent Change

    +0.34%
    DBD price was up +0.34% on Dec 9, 2025

    Price YTD Change

    +52.42%
    DBD price is up +52.42% since January 1st

    Price 1-Year Change

    +34.76%
    DBD price is up +34.76% year-on-year

    Price 3-Year Change

    -
    DBD price 3-year change is unknown

    Price Range

    Price All-Time High

    $67.02
    DBD price is currently -2.12% below its historical high of $67.02

    Price 3-Year Low

    $16.50
    DBD price is currently +297.58% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $2.35B
    DBD market cap is $2.35 billion

    Market Cap 3-Year Change

    -
    DBD market cap 3-year change is unknown

    Market Cap All-Time High

    $2.39B
    DBD market cap is currently -1.63% below its historical high of $2.39 billion

    Market Cap Sector Percentile

    62.06%
    DBD market cap is higher than 62.06% of companies in Technology sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -4.55%
    DBD shares outstanding is down -4.55% year-on-year

    Shares Outstanding 3-Year Change

    -54.64%
    DBD shares outstanding is down -54.64% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.20
    DBD beta is 1.20

    200-day SMA

    $53.81
    DBD price is currently +21.91% above its 200-day simple moving average

    50-day SMA

    $60.72
    DBD price is currently +8.03% above its 50-day simple moving average

    14-Day RSI

    59.38
    DBD 14-day relative strength index is 59.38

    Volume

    2.27
    DBD 30-day relative volume is 2.27

    ATR

    $1.87
    DBD average true range is $1.87

    10-day Historical Volatility

    20.47%
    DBD 10-day historical volatility is 20.47%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.75B
    DBD annual revenue is $3.75 billion

    Revenue Analysts Estimate

    $3.82B
    DBD annual revenue is currently -1.68% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -0.25%
    DBD annual revenue is down -0.25% year-on-year

    Revenue Sector Percentile

    84.26%
    DBD annual revenue is higher than 84.26% of companies in Technology sector

    EPS

    EPS

    -$0.44
    DBD annual earnings per share is -$0.44

    EPS Analysts Estimate

    $4.12
    DBD annual earnings per share is currently -110.64% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -101.2%
    DBD annual earnings per share is down -101.2% year-on-year

    EPS Sector Percentile

    36.34%
    DBD annual earnings per share is higher than 36.34% of companies in Technology sector

    Profit

    Gross Profit

    $947.80M
    DBD annual gross profit is $947.80 million

    Gross Margin

    25.27%
    DBD annual gross profit margin is 25.27%

    Operating Profit

    $287.20M
    DBD annual operating income is $287.20 million

    Operating Margin

    -67.08%
    DBD annual operating profit margin is -67.08%

    Net Income

    -$14.50M
    DBD annual net profit is -$14.50 million

    Net Margin

    -0.39%
    DBD annual net profit margin is -0.39%

    Expenses

    Total Expenses

    $3.77B
    DBD annual total expenses is $3.77 billion

    Operating Expenses

    $660.60M
    DBD annual total operating expenses is $660.60 million

    Cost Of Goods Sold

    $2.80B
    DBD annual cost of goods sold is $2.80 billion

    Selling, General & Administrative Expenses

    $0.00
    DBD annual SG&A is $0.00

    Depreciation & Amortization

    $132.30M
    DBD annual D&A is $132.30 million

    Interest Expense

    $0.00
    DBD annual interest expense is $0.00

    Income Tax

    $64.30M
    DBD annual income tax is $64.30 million

    EBIT & EBITDA

    EBIT

    $287.20M
    DBD annual earnings before interest & taxes is $287.20 million

    EBITDA

    $419.50M
    DBD annual EBITDA is $419.50 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $3.54B
    DBD annual total assets is $3.54 billion

    Non Current Assets

    $1.88B
    DBD annual long term assets is $1.88 billion

    Current Assets

    $1.67B
    DBD annual total current assets is $1.67 billion

    Cash and Cash Equivalents

    $328.20M
    DBD annual cash & cash equivalents is $328.20 million

    Accounts Receivable

    $588.50M
    DBD annual accounts receivable is $588.50 million

    Inventory

    $528.10M
    DBD annual inventory is $528.10 million

    Liabilities

    Total Liabilities

    $2.61B
    DBD annual total liabilities is $2.61 billion

    Long Term Liabilities

    $319.60M
    DBD annual total long term liabilities is $319.60 million

    Current Liabilities

    $1.27B
    DBD annual current liabilities is $1.27 billion

    Accounts Payable

    $460.20M
    DBD annual accounts payable is $460.20 million

    Debt

    Total Debt

    $1.07B
    DBD annual total debt is $1.07 billion

    Total Debt 1-Year Change

    -21.79%
    DBD annual total debt is down -21.79% year-on-year

    Long Term Debt

    $1.02B
    DBD annual long term debt is $1.02 billion

    Short Term Debt

    $48.00M
    DBD annual short term debt is $48.00 million

    Equity & Capital

    Shareholders Equity

    $929.80M
    DBD annual stockholders equity is $929.80 million

    Book Value

    $929.80M
    DBD annual book value is $929.80 million

    Retained Earnings

    -$1.10M
    DBD annual retained earnings is -$1.10 million

    Working Capital

    $401.60M
    DBD annual working capital is $401.60 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $149.20M
    DBD annual cash from operations is $149.20 million

    Cash From Operations 1-Year Change

    +158.05%
    DBD annual cash from operations is up +158.05% year-on-year

    Cash From Investing

    -$45.50M
    DBD annual cash from investing is -$45.50 million

    Cash From Investing 1-Year Change

    -26.04%
    DBD annual cash from investing is down -26.04% year-on-year

    Cash From Financing

    -$366.50M
    DBD annual cash from financing is -$366.50 million

    Cash From Financing 1-Year Change

    -165.5%
    DBD annual cash from financing is down -165.5% year-on-year

    CAPEX

    CAPEX

    $40.40M
    DBD annual capital expenditures is $40.40 million

    CAPEX 1-Year Change

    -15.48%
    DBD annual capital expenditures is down -15.48% year-on-year

    Free Cash Flow

    Free Cash Flow

    $108.80M
    DBD annual free cash flow is $108.80 million

    Free Cash Flow 1-Year Change

    +135.7%
    DBD annual free cash flow is up +135.7% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    25.27%
    DBD annual gross profit margin is 25.27%

    Operating Margin

    -67.08%
    DBD annual operating profit margin is -67.08%

    Net Margin

    -0.39%
    DBD annual net profit margin is -0.39%

    ROA & ROE

    ROA

    -0.38%
    DBD annual return on assets is -0.38%

    ROE

    -1.44%
    DBD annual return on equity is -1.44%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    48.08
    DBD price to earnings ratio is 48.08

    PE Ratio Sector Percentile

    70.03%
    DBD price to earnings ratio is higher than 70.03% of companies in Technology sector

    PB Ratio

    PB Ratio

    2.13
    DBD price to book ratio is 2.13

    PB Ratio Sector Percentile

    43.21%
    DBD price to book ratio is higher than 43.21% of companies in Technology sector

    PS Ratio

    PS Ratio

    0.64
    DBD price to sales ratio is 0.64

    PS Ratio Sector Percentile

    15.44%
    DBD price to sales ratio is higher than 15.44% of companies in Technology sector

    Enterprise value

    Enterprise Value

    $3.14B
    DBD enterprise value is $3.14 billion

    Enterprise Value Sector Percentile

    64.65%
    DBD enterprise value is higher than 64.65% of companies in Technology sector

    EV/EBITDA

    EV/EBITDA

    7.65
    DBD EV/EBITDA is 7.65

    EV/EBITDA Sector Percentile

    46.73%
    DBD EV/EBITDA is higher than 46.73% of companies in Technology sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.32
    DBD annual current ratio is 1.32

    Quick Ratio

    0.90
    DBD annual quick ratio is 0.90

    Leverage

    Debt To Equity

    1.15
    DBD annual debt to equity ratio is 1.15

    Interest Coverage Ratio

    -
    DBD annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    7
    DBD piotroski f-score is 7

    Altman Z-Score

    2.00
    DBD altman z-score is 2.00

    Analyst ratings

    Recent major analysts updates

    Nov 18, 25 Wedbush
    Outperform
    Nov 6, 25 Wedbush
    Outperform
    Oct 28, 25 Wedbush
    Outperform
    Aug 19, 25 DA Davidson
    Buy
    Aug 7, 25 Wedbush
    Outperform
    Feb 27, 25 DA Davidson
    Buy
    Aug 9, 24 DA Davidson
    Buy
    Aug 8, 24 Wedbush
    Outperform
    Jul 25, 24 Wedbush
    Outperform
    May 3, 24 Wedbush
    Outperform

    Institutional Ownership

    Screeners with DBD included

    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Most recommended stocks
    Stocks above SMA 50
    Stocks below analysts price target
    Technology sector
    Software Development Companies
    All stocks
    • What is the ticker symbol for Diebold Nixdorf, Incorporated?
    • Does Diebold Nixdorf, Incorporated pay dividends?
    • What sector is Diebold Nixdorf, Incorporated in?
    • What industry is Diebold Nixdorf, Incorporated in?
    • What country is Diebold Nixdorf, Incorporated based in?
    • When did Diebold Nixdorf, Incorporated go public?
    • Is Diebold Nixdorf, Incorporated in the S&P 500?
    • Is Diebold Nixdorf, Incorporated in the NASDAQ 100?
    • Is Diebold Nixdorf, Incorporated in the Dow Jones?
    • When was Diebold Nixdorf, Incorporated's last earnings report?
    • When does Diebold Nixdorf, Incorporated report earnings?

    What is the ticker symbol for Diebold Nixdorf, Incorporated?

    The ticker symbol for Diebold Nixdorf, Incorporated is NYSE:DBD

    Does Diebold Nixdorf, Incorporated pay dividends?

    No, Diebold Nixdorf, Incorporated does not pay dividends

    What sector is Diebold Nixdorf, Incorporated in?

    Diebold Nixdorf, Incorporated is in the Technology sector

    What industry is Diebold Nixdorf, Incorporated in?

    Diebold Nixdorf, Incorporated is in the Software Development industry

    What country is Diebold Nixdorf, Incorporated based in?

    Diebold Nixdorf, Incorporated is headquartered in United States

    When did Diebold Nixdorf, Incorporated go public?

    Diebold Nixdorf, Incorporated's initial public offering (IPO) was on August 14, 2023

    Is Diebold Nixdorf, Incorporated in the S&P 500?

    No, Diebold Nixdorf, Incorporated is not included in the S&P 500 index

    Is Diebold Nixdorf, Incorporated in the NASDAQ 100?

    No, Diebold Nixdorf, Incorporated is not included in the NASDAQ 100 index

    Is Diebold Nixdorf, Incorporated in the Dow Jones?

    No, Diebold Nixdorf, Incorporated is not included in the Dow Jones index

    When was Diebold Nixdorf, Incorporated's last earnings report?

    Diebold Nixdorf, Incorporated's most recent earnings report was on November 5, 2025

    When does Diebold Nixdorf, Incorporated report earnings?

    The next expected earnings date for Diebold Nixdorf, Incorporated is February 11, 2026
    On this page